General and Pelvic Endoscopic Surgery Devices
For inquiries about purchasing this report or becoming a subscriber, please contact us at [email protected].
In 2022, approximately 29.1 million endoscopic general and pelvic procedures were performed worldwide. Endoscopic surgery provides a minimally invasive approach that results in reduced trauma and faster recovery times for patients. The global market for endoscopic general and pelvic surgery devices totaled $16.7bn in 2022. A key factor underlying the growth of the market is the conversion of procedures from open to endoscopic surgery, which has been a continuing trend, driven by advances in endoscopic imaging technology that have led to more detailed, brighter images.
In addition, advances in surgical instrument technology, such as small diameter devices fabricated from advanced materials, and the introduction of robotic surgery, have expanded the range of procedures that may be performed endoscopically. This new report from Meddevicetracker includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for general and pelvic endoscopic surgery. This market is segmented by product type (including hand instruments, endoscopes, access devices, ancillary devices, access site closure devices, and insufflation products). Regions covered by this analysis include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2022–27.
Related Medtech Insight articles:
- Olympus Gets Greenlight From FDA For Its New Endoscopy System
- Boston Scientific Makes Half Billion Dollar GI Endosurgery Play
- News We’re Watching – US FDA Updates, Digital Therapeutics Legislation, AI Endoscopies, Monkeypox EUA, And New AdvaMed Chair
- Subscribe to Medtech Insight to view these articles and more!